Skip to content

Mechanism of dexmedetomidine on lung injury induced by limb ischemia-reperfusion in replantation of severed fingers

Mechanism of dexmedetomidine on lung injury induced by limb ischemia-reperfusion in replantation of severed fingers

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075039
Enrollment
Unknown
Registered
2023-08-23
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung injury

Interventions

Control group:Total intravenous general anesthesia
experimental group:Total intravenous general anesthesia added dexmedetomidine

Sponsors

the Third Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Emergency patients undergoing amputated finger replantation; (2) Age =16 years old, male or female; (3) American Society of Anesthesiologists (ASA) grade ?~?

Exclusion criteria

Exclusion criteria: (1) allergic to dexmedetomidine or its drug components; (2) severe heart block or severe ventricular dysfunction; (3) patients during pregnancy or lactation; (4) who underwent autogenous vascular transplantation due to the absence or necrosis of intrinsic vessels caused by crush or avulsion injury; (5) who did not agree to general anesthesia; (6) cognitive impairment or inability to communicate effectively; (7) who were deemed unsuitable for the trial by the investigators.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative lung injury;Oxygenation index, pH, partial pressure of oxygen, partial pressure of carbon dioxide,SOD, MDA, CRP, Tnf-a, IL-1ß and IL-6 at T0-T2 and on the first day after surgery (T3);

Secondary

MeasureTime frame
Vital signs were recorded 5min before induction of anesthesia (T0), 5min after induction of anesthesia (T1), and at the end of surgery (T2);The operation time;tourniquet use time;intraoperative fluid infusion volume;intraoperative urine volume;Adverse events during hospitalization;

Countries

China

Contacts

Public ContactLu Kejian

the Third Affiliated Hospital of Guangxi Medical University

xplook@aliyun.com+86 139 7816 8887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026